APA (7th ed.) Citation

Salvi, S., Casadio, V., Conteduca, V., Burgio, S. L., Menna, C., Bianchi, E., . . . De Giorgi, U. (2015). Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone. British Journal of Cancer, 112(10), 1717. https://doi.org/10.1038/bjc.2015.128

Chicago Style (17th ed.) Citation

Salvi, S., et al. "Circulating Cell-free AR and CYP17A1 Copy Number Variations May Associate with Outcome of Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone." British Journal of Cancer 112, no. 10 (2015): 1717. https://doi.org/10.1038/bjc.2015.128.

MLA (9th ed.) Citation

Salvi, S., et al. "Circulating Cell-free AR and CYP17A1 Copy Number Variations May Associate with Outcome of Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone." British Journal of Cancer, vol. 112, no. 10, 2015, p. 1717, https://doi.org/10.1038/bjc.2015.128.